A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Translational Research Laboratory Core Bookmark and Share

Translational Research Laboratory Core

The mission of the Translational Research Laboratory (TRL) Core is to facilitate, implement, and support the needs of basic science researchers, clinical researchers, population researchers and clinical science collaborations. Interactions between basic scientists and clinicians are fostered to ensure the inclusion of scientifically sound correlative studies in clinical trials, and also to enable and assist research studies using clinical samples from patients enrolled in clinical trials. Emphasis is placed on the pursuit of institutional collaborations, allowing TRL and other Core laboratories to work closely together.
 
The following services will be offered:
 
  •     Bio-specimen repository of clinical and population research protocol samples
    •     Receiving, processing and storing human samples
    •     Database management system to centralize information
       
  •     Creation of cell lines from tumor
     
  •     Circulating tumor cell (CTC) and other rare events studies
    •     CTC enumeration, enrichment
    •     Single CTC isolation, whole genome amplification from single cell for genetic characterization
    •     Pure population collection from Formalin-fixed, paraffin-embedded (FFPE) tissue samples, DNA preparation for genetic characterization
    •     Rare living cell sorting for RNAseq analysis
       
  •     Molecular biology – based translational studies
    •     Cell proliferation assay and drug cytotoxicity analysis
    •     DNA and RNA isolation and quantification
    •     Design and optimization of real-time PCR analysis
    •     Protein isolation, western blot, and multiplex ELISA assay
    •     Other molecular biology assays.
 
 
 

Pricing

Current pricing can be found on our iLab site. Please contact us for further questions.

 

 

Contact Us

Raju K. Pillai, M.D.
Core Director
(626) 256-HOPE x89292
 
Lixin Yang
Assistant Research Professor
(626) 256-HOPE x62070
 
Yafan Wang          
Senior Research Associate
(626) 256-HOPE x65544
 
Linling Chen
Research Associate II
(626) 256-HOPE x32182
 
City of Hope and Beckman Research Institute     
1500 E Duarte Road
Duarte, CA 91010-3000
Beckman Building, Room 4320

Translational Research Laboratory Core

Translational Research Laboratory Core

The mission of the Translational Research Laboratory (TRL) Core is to facilitate, implement, and support the needs of basic science researchers, clinical researchers, population researchers and clinical science collaborations. Interactions between basic scientists and clinicians are fostered to ensure the inclusion of scientifically sound correlative studies in clinical trials, and also to enable and assist research studies using clinical samples from patients enrolled in clinical trials. Emphasis is placed on the pursuit of institutional collaborations, allowing TRL and other Core laboratories to work closely together.
 
The following services will be offered:
 
  •     Bio-specimen repository of clinical and population research protocol samples
    •     Receiving, processing and storing human samples
    •     Database management system to centralize information
       
  •     Creation of cell lines from tumor
     
  •     Circulating tumor cell (CTC) and other rare events studies
    •     CTC enumeration, enrichment
    •     Single CTC isolation, whole genome amplification from single cell for genetic characterization
    •     Pure population collection from Formalin-fixed, paraffin-embedded (FFPE) tissue samples, DNA preparation for genetic characterization
    •     Rare living cell sorting for RNAseq analysis
       
  •     Molecular biology – based translational studies
    •     Cell proliferation assay and drug cytotoxicity analysis
    •     DNA and RNA isolation and quantification
    •     Design and optimization of real-time PCR analysis
    •     Protein isolation, western blot, and multiplex ELISA assay
    •     Other molecular biology assays.
 
 
 

Pricing

Pricing

Current pricing can be found on our iLab site. Please contact us for further questions.

 

 

Translational Research Team

Contact Us

Raju K. Pillai, M.D.
Core Director
(626) 256-HOPE x89292
 
Lixin Yang
Assistant Research Professor
(626) 256-HOPE x62070
 
Yafan Wang          
Senior Research Associate
(626) 256-HOPE x65544
 
Linling Chen
Research Associate II
(626) 256-HOPE x32182
 
City of Hope and Beckman Research Institute     
1500 E Duarte Road
Duarte, CA 91010-3000
Beckman Building, Room 4320
Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 

Recognized nationwide for its innovative biomedical research, City of Hope's Beckman Research Institute is home to some of the most tenacious and creative minds in science.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 
Media Inquiries/Social Media
 
CONNECT WITH US
Facebook  Twitter  YouTube  Blog
 


NEWS & UPDATES
  • Internship programs are a rite of summer for many high-achieving students. For five Caltech pre-med students, each hoping to make a mark in medicine, that rite led them to the City of Hope campus in Duarte, California, for an exceptional learning experience. The collaboration between the two high-profile resear...
  • Urinary tract stones are hard masses, or calculi, that form in the urinary tract and may cause pain, bleeding or an infection, or even block of the flow of urine. Urinary tract stones begin to form in a kidney and may enlarge in a ureter or the bladder. Depending on where a stone is located, […]
  • Every summer, hospitals nationwide experience a shortage of blood donations. This summer is no exception. Nearly 1.7 million new cancer cases are expected to be diagnosed in the U.S. this year,  and many of those patients will need blood transfusions during their treatment. Patients at City of Hope alone rely o...
  • Non-Hodgkin lymphoma facts: Non-Hodgkin lymphoma is a cancer that starts in cells called lymphocytes, which are part of the body’s immune system. Lymphocytes are in the lymph nodes and other lymphoid tissues (such as the spleen and bone marrow). Non-Hodgkin lymphoma is one of the most common cancers in the U.S....
  • Few clinical cancer trials include older adults – and yet, more than 60 percent of cancer cases in the United States occur in people age 65 and older. The result is a dearth of knowledge on how to treat the very population most likely to be diagnosed with cancer. Now, the American Society of Clinical […]
  • Scientists at City of Hope and UCLA have become the first to inhibit the expression of a protein, called TWIST that promotes tumor invasion and metastasis when activated by cancer cells. As such, they’ve taken the first step in developing a potential new therapy for some of the deadliest cancers, including ovar...
  • Upon completing her final round of chemotherapy for ovarian cancer earlier this month, Maria Velazquez-McIntyre, a 51-year-old Antelope Valley resident, celebrated the milestone by giving other patients a symbol of hope – a Survivor Bell. The bell may look ordinary, but for cancer patients undergoing chemothera...
  • Many Americans understand that obesity is tied to heart disease and diabetes but, according to a new survey, too few – only 7 percent – know that obesity increases the risk of cancer. Specific biological characteristics can increase cancer risk in obese people, and multiple studies have shown correlations betwe...
  • As breast cancer survivors know, the disease’s impact lingers in ways both big and small long after treatment has ended. A new study suggests that weight gain – and a possible corresponding increase in heart disease and diabetes risk – may be part of that impact. In the first study to evaluate weight chan...
  • Becoming what’s known as an independent scientific researcher is no small task, especially when working to translate research into meaningful health outcomes. Yet that independent status is vital, enabling researchers to lead studies and avenues of inquiry that they believe to be promising. Clinicians, especial...
  • 720 days. That’s how long Alex Tung, 38, had to give up surfing after being diagnosed with acute myeloid leukemia. For most people, even some surfers, such a hiatus wouldn’t be a big deal, but for Tung, surfing has been everything. The Southern California resident began surfing when he was in elemen...
  • There are few among us who have not experienced loss of a friend or loved one, often without warning, or like those of us who care for people with cancer, after a lingering illness. It is a time when emotions run high and deep, and as time passes from the moment of loss, we often […]
  • For the past four years, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., has been studying how breast cancer cells spread, or metastasize, to the brain, where they become life-threatening tumors. Known as secondary brain tumors, these cancers have become increasingly common as treatment advances have ena...
  • Cutaneous T cell lymphomas are types of non-Hodgkin lymphoma that arise when infection-fighting white blood cells in the lymphatic system – called lymphocytes – become malignant and affect the skin. A primary symptom is a rash that arises initially in areas of the skin that are not normally exposed to sunlight....
  • There’s science camp, and then there’s “mystery” science camp. City of Hope’s new science camp for middle school students is of the especially engaging latter variety. From Monday, July 13, to Friday, July 17, rising middle-school students from across the San Gabriel Valley were presented with a “patient” with ...